William K. Heiden, CEO at AMAG PHARMACEUTICALS INC. (AMAG), sold 20,000 shares at $75.00 ($1.5M) on 2015-07-15, disclosed to the SEC on 2015-07-17.
Scheduled sale ($1.5M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMAG | BUY | 2019-05-09 | $107K | — | Filing → |
| AMAG | SELL | 2018-08-08 | $125K | — | Filing → |
| AMAG | SELL | 2018-06-05 | $500K | — | Filing → |